Antiplatelet Use and Ischemic Stroke Risk in Minor Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the POINT Trial.
Mohammad AnadaniAdam H de HavenonNils HenningerLindsey R KuohnBrian Mac GroryKaren L FurieAnthony S KimJ Donald EastonS Claiborne JohnstonShadi YaghiPublished in: Stroke (2021)
In patients with minor stroke and high-risk transient ischemic attack, dual antiplatelet therapy reduces the risk of ischemic stroke regardless of premorbid antiplatelet use.